Akeso

Akeso, a pharmaceutical preparation manufacturer based in CN, has reported the following carbon emissions data:

For 2024, Akeso reported Scope 1 emissions of approximately 6,408,460 kg CO2e and Scope 2 emissions of approximately 46,019,810 kg CO2e, resulting in a combined total of approximately 52,428,270 kg CO2e.

In 2023, Akeso's Scope 1 emissions were approximately 1,397,580 kg CO2e, and Scope 2 emissions were approximately 26,831,850 kg CO2e, for a combined total of approximately 28,229,430 kg CO2e. Their reporting for this year also noted greenhouse gas emissions per person as approximately 10,160 kg CO2e.

For 2022, Akeso reported Scope 1 emissions of approximately 82,000 kg CO2e and Scope 2 emissions of approximately 23,658,020 kg CO2e, contributing to a combined total of approximately 23,740,020 kg CO2e. Greenhouse gas emissions per person were approximately 10,140 kg CO2e.

In 2021, Akeso's Scope 1 emissions were approximately 35,230 kg CO2e and Scope 2 emissions were approximately 4,495,650 kg CO2e, totalling approximately 4,530,880 kg CO2e. Greenhouse gas emissions per person were reported as approximately 2,430 kg CO2e.

Akeso's reporting indicates a focus on Scope 1 and Scope 2 emissions, with Scope 3 data, specifically purchased goods and services, being a missing data point in their disclosures for the reported years. The company has not publicly disclosed specific reduction targets or commitments to initiatives such as the Science Based Targets initiative (SBTi) or the Climate Pledge.